Answers are grounded in this paper and cite their sources.
Technologic advances have revolutionized the clinical laboratory over the years and, most recently, the development and miniaturization of electrochemical sensors, biosensors, and fiber-optic sensors have allowed testing to move closer to the patient. This includes noninvasive and invasive sensors that provide continuous monitoring of patient condition in real time. Noninvasive sensors include pulse oximetry, transcutaneous electrodes for Po2 and Pco2, and transcutaneous bilirubin monitors. Continuous invasive systems include ex vivo monitors for pH and blood gases that may use fluorescence chemistry or optical or electrochemical sensors and fiber-optic sensors for continuous in vivo monitoring ofpH and blood gases. Several of the newest advances in noninvasive monitors involve the analysis of glucose in patients with diabetes.
No takes yet. Share an insight, caveat, or question.
Mary F. Burritt (1998) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: